ORIGINAL RESEARCH
Accepted on 25 Jun 2025
Dynamic Circulating Tumor DNA Indicates Pathological Benefits of Additional Neoadjuvant Chemoimmunotherapy Courses for Locally Advanced Non-Small-Cell Lung Cancer Patients
doi 10.3389/fonc.2025.1563315
- 159 views